Rieger Jayson
Verrica Pharmaceuticals Inc. · CEO and President
Rieger Jayson is listed in filings as CEO and President at Verrica Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Nov 25, 2025, including purchase activity. Recent filings connect the profile to Verrica Pharmaceuticals Inc. (VRCA). The current snapshot covers public activity from Nov 6, 2024 to Nov 25, 2025. Reported amounts are shown as $400.1K to $756.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $250k280.9k shares | BuyNov 22, 2024 | $0.89 | $6.14 | |
| $187k140.4k shares | BuyNov 22, 2024 | $1.34 | $6.14 | |
| $150k140.4k shares | BuyNov 22, 2024 | $1.07 | $6.14 |